Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017842
Filing Date
2022-11-14
Accepted
2022-11-14 17:02:45
Documents
73
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q azyo-20220930x10q.htm   iXBRL 10-Q 1724199
2 EX-10.3 azyo-20220930xex10d3.htm EX-10.3 25917
3 EX-10.4 azyo-20220930xex10d4.htm EX-10.4 66741
4 EX-31.1 azyo-20220930xex31d1.htm EX-31.1 14669
5 EX-31.2 azyo-20220930xex31d2.htm EX-31.2 14658
6 EX-32.1 azyo-20220930xex32d1.htm EX-32.1 6775
7 EX-32.2 azyo-20220930xex32d2.htm EX-32.2 6729
  Complete submission text file 0001558370-22-017842.txt   7083312

Data Files

Seq Description Document Type Size
8 EX-101.SCH azyo-20220930.xsd EX-101.SCH 52474
9 EX-101.CAL azyo-20220930_cal.xml EX-101.CAL 42685
10 EX-101.DEF azyo-20220930_def.xml EX-101.DEF 253399
11 EX-101.LAB azyo-20220930_lab.xml EX-101.LAB 476170
12 EX-101.PRE azyo-20220930_pre.xml EX-101.PRE 372694
67 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20220930x10q_htm.xml XML 1054499
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 221387278
SIC: 2836 Biological Products, (No Diagnostic Substances)